|
End-of-day quote
Shanghai S.E.
01/09/2026
|
5-day change | 1st Jan Change | ||
| 9.330 CNY | +1.74% |
|
-5.95% | -3.81% |
| 08-27 | Sinotherapeutics Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 04-29 | Sinotherapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 4.19B 623M 538M 506M 461M 866M 59.15B 871M 5.98B 2.33B 30.09B 2.34B 2.29B 99.77B | P/E 2024 |
35.9x | P/E 2025 | 88.2x |
|---|---|---|---|---|---|
| Enterprise Value | 3.44B 512M 442M 416M 379M 712M 48.61B 716M 4.91B 1.91B 24.73B 1.92B 1.88B 81.99B | EV / Sales 2024 |
7.4x | EV / Sales 2025 | 8.08x |
| Free-Float |
24.34% | Yield 2024 |
0.62% | Yield 2025 | 0.36% |
| 1 day | +1.74% | ||
| 1 week | -5.95% | ||
| Current month | +1.74% | ||
| 1 month | +12.95% | ||
| 3 months | +7.00% | ||
| 6 months | -9.24% | ||
| Current year | -3.81% |
| 1 week | 9.07 |  | 9.84 |
| 1 month | 7.7 | | 11.33 |
| Current year | 7.02 | | 11.33 |
| 1 year | 7.02 | | 11.52 |
| 3 years | 6.3 | | 14 |
| 5 years | 6.3 | | 28 |
| 10 years | 6.3 | | 28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Jie Guo
CEO | Chief Executive Officer | 53 | 05/04/2023 |
Yi Ming Wu
DFI | Director of Finance/CFO | 57 | 29/04/2025 |
Hui Zhang
IRC | Investor Relations Contact | 44 | 30/05/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Jun Ye
CHM | Chairman | 53 | 17/08/2020 |
Xiao Ming Ying
BRD | Director/Board Member | 58 | 31/07/2012 |
Si Yu Shen
BRD | Director/Board Member | 44 | 31/08/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.74% | -5.95% | -20.26% | -13.93% | 623M | |
| +0.16% | +1.71% | +23.43% | +74.23% | 48.77B | |
| -1.41% | -0.12% | +51.83% | +118.74% | 40.67B | |
| -1.10% | +0.28% | +15.77% | +85.85% | 12.27B | |
| -0.65% | +0.73% | -9.96% | +14.05% | 12.11B | |
| +0.57% | +1.73% | +31.59% | +153.11% | 9.28B | |
| -0.15% | -1.87% | +25.21% | +46.24% | 7.55B | |
| -1.43% | -0.08% | +26.97% | +219.93% | 7.35B | |
| +0.10% | -0.06% | +45.84% | -10.56% | 7.3B | |
| -0.13% | -0.16% | -40.47% | +15.85% | 5.25B | |
| Average | -0.24% | +0.53% | +15.00% | +70.35% | 15.12B | |
| Weighted average by Cap. | -0.53% | +1.23% | +27.22% | +86.36% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 512M 76.12M 65.66M 61.76M 56.27M 106M 7.22B 106M 730M 284M 3.67B 286M 280M 12.18B | 447M 66.44M 57.31M 53.91M 49.11M 92.36M 6.31B 92.86M 637M 248M 3.21B 249M 244M 10.64B |
| Net income | 128M 19M 16.39M 15.42M 14.04M 26.41M 1.8B 26.55M 182M 70.94M 917M 71.33M 69.79M 3.04B | 47.48M 7.06M 6.09M 5.73M 5.22M 9.82M 670M 9.87M 67.76M 26.38M 341M 26.52M 25.95M 1.13B |
| Net Debt | -734M -109M -94.14M -88.55M -80.67M -152M -10.36B -153M -1.05B -407M -5.27B -410M -401M -17.47B | -746M -111M -95.79M -90.11M -82.09M -154M -10.54B -155M -1.07B -415M -5.36B -417M -408M -17.78B |
Employees
319
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/09/26 | CN¥9.330 | +1.74% | 5,751,044 |
| 31/08/26 | CN¥9.170 | -3.37% | 6,437,158 |
| 28/08/26 | CN¥9.490 | -2.97% | 6,325,415 |
| 27/08/26 | CN¥9.780 | +0.62% | 5,137,775 |
| 26/08/26 | CN¥9.720 | -2.02% | 6,249,619 |
- Stock Market
- Stocks
- 688247 Stock
Select your edition
All financial news and data tailored to specific country editions
